Sanifit Therapeutics
Entry
2019
Hold
2yr
Exit
2021
Who owns Sanifit Therapeutics?
Sanifit Therapeutics was owned by Columbus Venture Partners through Columbus Life Science Fund II (2019 vintage) from 2019 to 2021, exited via Trade Sale. Across its history, Sanifit Therapeutics has been through 4 private equity ownership periods, detailed in the timeline below.
Buyer identity available on Pro.
Hand-verified · updated 2026-08-03
Most recent investor
Columbus Venture PartnersColumbus Life Science Fund II · 2019 · Life Sciences VC
4 ownership periods · full history below
Key facts
HQSpain
SectorBiotech
StatusAcquired
Key takeaways
- ·Fully exited in 2021.
- ·Average hold across 4 realized cycles: 7 years.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Exited
Last exited in 2021 to .
Co-invest · 4 holders · 2006 · 2021
Columbus Venture PartnersExited 2021
2019 · 2021(2yr) · Columbus Life Science Fund II · 2019 · Life Sciences VC
Trade Sale · to
MOIC
–
Alta Life SciencesExited 2021
2019 · 2021(2yr) · Alta Life Sciences Spain I FCR · 2016 · Life Sciences VC
Trade Sale · to
MOIC
–
More from Columbus Life Science Fund II
Other portfolio companies in the same fund.
Minoryx Therapeutics
Active
Biotech
Spain· 2022
NeRRe Therapeutics
Active
Biotech
United Kingdom· 2021
Highlight Therapeutics
Active
Biotech
Spain· 2020
RECOVID Solutions
Exited 2022
HealthTech
Spain· 2020
to
Viralgen Commercial
Exited 2021
Biotech
Spain· 2019
to
Radioterapia de Protones
Exited 2024
Healthcare
Spain· 2017
to
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Sanifit Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on Sanifit Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue